‘About 20 to 25 centres in India practice sentinel lymph node biopsy’

Sentinel lymph node biopsy is an alternate approach to complete axillary node dissection for breast cancer patients. Dr Vaishali Zamre, Senior Consultant, Surgical Oncology, Action Cancer Hospital explains the benefits of this procedure to Raelene Kambli

What is sentinel lymph node biopsy and how is it conducted?

Dr Vaishali Zamre

Sentinel lymph node biopsy is a surgical approach used for identification of specific lymph nodes that are called as sentinel nodes. The world sentinel means ‘sentry’ or ‘guard’. In cancer, a sentinel lymph node is referred to as a lymph node that receives lymph from the cancer in a patient and thus acts as a first site for spread of cancer to lymph nodes.

In the normal course of cancer management, removal of lymph nodes is a routine part of cancer surgery for a variety of cancers. As an example, lymph nodes in the armpit are removed for breast cancer surgery (axillary lymph node dissection). Removal of all the axillary lymph nodes is the standard procedure that has been in use for more than a century. This process however leads to some problems that include edema of the arm (lymphedema), weakness of shoulder and stiffness of shoulder (impaired shoulder function).

It has been noticed in large studies that lymph nodes in axilla may not contain cancer in a one third to two third of patients (35 to 65 per cent). In such cases, removal of axillary lymph nodes does not provide benefit to the patient while the side effects of axillary dissection still occur.

To reduce the problems related to removal of axillary lymph nodes, we need to be able to identify patients whose nodes in the axilla do not contain cancer. Sentinel lymph node biopsy is an approach that can identify presence of cancer in axillary nodes (in breast cancer cases) and allow us to do complete removal of axillary nodes only in patient who have cancer. With this approach, axillary dissection can be avoided in patients who do not actually need it and thus avoid side effects of axillary dissection that is edema of the arm and shoulder stiffness.

Sentinel lymph node biopsy is conducted using a combination of two techniques. We use blue dye and radioisotope. A special blue dye is injected in the breast at the time of surgery and lymph nodes in the axilla are identified by those that have taken up the blue dye. Such stained nodes are part of the sentinel lymph node group. Also, radioisotope labeled colloid is injected in the breast a few hours before surgery. Then, scanning of the patient is done using a gamma camera to look for uptake of radioisotope in the sentinel nodes. At the time of surgery, a special equipment called handheld gamma probe is used to identify such nodes in the axilla. Thus, both dye method and radioisotope method are combined to get the highest accuracy rates for sentinel node identification. The sentinel nodes that have been identified are sent to the pathologist for immediate assessment using ‘frozen section’ testing. If there is cancer in these nodes, remaining nodes are removed. Otherwise, remaining nodes are not removed and patient does not have the risk of side effects of node removal.

What are the advantages and disadvantages of this procedure?

The advantages have been mentioned above. Main advantage is avoidance of unnecessary axillary dissection and its side effects.

Disadvantage can be described in terms of the need for specialised infrastructure and expertise. Such infrastructure and expertise is available at limited centres in the metropolitan cities and not at all outside the metropolitan cities.

Are there any specific guidelines associated with the use of this technique?

It needs to be highlighted that there are no Indian guidelines pertaining to sentinel lymph node biopsy. This, however, is in line with the general lack of Indian guidelines about all other issues that affect cancer care, including screening, prevention, treatment etc.

Sentinel lymph node biopsy is recommended for patients in whom lymph nodes in the axilla are not enlarged and felt on clinical examination. Internationally, it is recommended that a combination of dye method and radioisotope method should be used for best results. Further, each centre that is doing the procedure should do internal audit and keep monitoring its success rate. Proper training of persons practising this procedure is also important. Such training is acquired through conferences, workshops and visits to centres that are practising this procedure.

How long have you been practising this technique?

In Action Cancer Hospital, this procedure has been started about six months ago when the hospital acquired hand held gamma probe, allowing us to practice the combined approach.

How commonly is this procedure practised in India?

There is no validated information about this. However, as mentioned above such facility is available in only major metropolitan cities. There may be about 20 to 25 centres in India that are practising this procedure.

What is your message to the industry on the occasion of world cancer day?

On the occasion of world cancer day, some messages need to be reiterated:

  • Cancer is curable and fear of cancer is today a bigger enemy than the disease.
  • Many of the cancers can be prevented by avoided risk factors such as tobacco, adopting a healthy diet and lifestyle, having vaccination for HPV, Hepatitis B etc.
  • Awareness and information are very important weapons in the fight against cancer. Media (print/ electronic and digital) need to constantly work in this direction.
  • Regular health check-ups can lead to early diagnosis and very high cure rates for most cancers.
  • Cancer treatment is still a costly proposition for majority of Indians. The government and industry need to work together for reducing the cost of treatment. Specific attention is required for reducing the cost of anti-cancer medicines, making cancer care facilities available widely in the country and government support for establishment of cancer care facilities outside the metropolitan cities.

raelene.kambli@expressindia.com